Skip to main content

TEZSPIRE

NDC 55513-123 · Amgen Inc

Generic nametezepelumab-ekko
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)TEZEPELUMAB
Strength210 mg/1.9mL
Pharmacologic classThymic Stromal Lymphopoietin Blocker [EPC], Thymic Stromal Lymphopoietin Blockers [MoA]
Marketing categoryBLA

Packages

55513-123-01 — 1 CARTRIDGE in 1 CARTON (55513-123-01) / 1.91 mL in 1 CARTRIDGE

55513-123-96 — 1 CARTRIDGE in 1 CARTON (55513-123-96) / 1.91 mL in 1 CARTRIDGE

Billed under HCPCS

J2356 — Injection, tezepelumab-ekko, 1 mg Medicare Part B payment limit (ASP + 6%): $17.92

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55513-112 — tezepelumab-ekko

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels